| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |